Abbott Laboratories recalls blood glucose meters

Abbott Laboratories is recalling its FreeStyle InsuLinx Blood Glucose Meters after finding that they display and store incorrect test results for dangerously high blood sugar levels.

The Abbott Park, Ill., company says the meters will display and store readings for of 1,024 milligrams per deciliter or higher at much lower levels. That's an extremely high and rare level that requires immediate medical attention.

The inaccurate readings can lead to a delay in identifying the problem or incorrect treatment. Abbott says that can lead to serious injury or death.

Abbott says customers with the meter should contact its diabetes care customer service or download a software update that resolves the issue.

Johnson & Johnson announced a similar recall last month for several types of its blood glucose meters.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Abbott recalls millions of diabetes testing strips

Dec 22, 2010

(AP) -- The Food and Drug Administration says Abbott Laboratories is recalling up to 359 million testing strips used by diabetics because they can give falsely low blood sugar readings.

Recommended for you

Supermaterial gives rejected drugs a new chance

12 hours ago

More than 80 percent of all drug candidates in the pharma R&D suffer from poor solubility and are therefore rejected early in the drug discovery process. Now Uppsala University researchers show that the new ...

Risk of antibiotic overuse in aged care settings

Jul 21, 2014

Antibiotics are being overused in residential aged care facilities (RACFs), and more integrated efforts to improve antibiotic prescribing practices need to be introduced, researchers say. 

Ruconest approved for rare genetic disease

Jul 17, 2014

(HealthDay)—Ruconest has been approved by the U.S. Food and Drug Administration to treat hereditary angioedema, a genetic disease that leads to sudden and potentially fatal swelling of the hands, feet, limbs, face, intestinal ...

NIH system to monitor emerging drug trends

Jul 17, 2014

An innovative National Drug Early Warning System (NDEWS) is being developed to monitor emerging trends that will help health experts respond quickly to potential outbreaks of illicit drugs such as heroin and to identify increased ...

User comments